Edition:
United Kingdom

Takeda Pharmaceutical Co Ltd (4502.T)

4502.T on Tokyo Stock Exchange

4,449JPY
6:00am GMT
Change (% chg)

¥12 (+0.27%)
Prev Close
¥4,437
Open
¥4,507
Day's High
¥4,550
Day's Low
¥4,445
Volume
12,061,800
Avg. Vol
9,597,776
52-wk High
¥6,659
52-wk Low
¥3,498

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -101.78 March 22 Jan 2019

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 5 5 5
(2) OUTPERFORM 8 7 5 5
(3) HOLD 0 0 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.62 1.58 1.64 1.64

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-19 9 2,432,260.00 3,527,800.00 1,780,000.00 1,759,910.00
Year Ending Mar-20 10 3,511,820.00 3,626,930.00 3,050,000.00 1,818,860.00
Earnings (per share)
Quarter Ending Mar-19 1 -101.78 -101.78 -101.78 --
Year Ending Mar-19 8 122.83 238.47 -44.45 192.66
Year Ending Mar-20 6 -34.40 26.70 -88.17 221.58

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 432,000.00 449,834.00 17,834.00 4.13
Quarter Ending Mar-18 410,578.00 400,963.00 9,615.00 2.34
Quarter Ending Dec-17 447,897.00 488,152.00 40,255.34 8.99
Quarter Ending Sep-17 438,894.00 433,176.00 5,718.00 1.30
Quarter Ending Jun-17 419,498.00 448,240.00 28,742.50 6.85

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-19 2,432,260.00 2,432,260.00 1,767,330.00 1,764,800.00 1,759,910.00
Year Ending Mar-20 3,511,820.00 3,511,820.00 3,484,320.00 1,811,560.00 1,818,860.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-19 0 0 1 0
Year Ending Mar-20 0 0 1 0
Earnings